Page 16 - Casos Clínicos de Cardiologia em Intervenção

LA TOMOGRAFÍA DE COHERENCIA ÓPTICA EN LA ANGIOPLASTIA PRIMARIA
EN EL INFARTO DE MIOCARDIO

LuIS ALMeIdA-MORAIS, TIAGO MendOnçA, RuI CRuz FeRReIRA

Bibliografía | Bibliografia
1. Falk E, Nakano M, Bentzon JF, Finn AV, Virmani R. Update on acute coronary syndromes: the pathologists’ view. Eur Heart J. 2013; 34(10): 719-728 [DOI:
10.1093/eurheartj/ehs411].
2. Jia H, Abtahian F, Aguirre AD, Lee S, Chia S, Lowe H, et al. In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome
by intravascular optical coherence tomography. J Am Coll Cardiol. 2013; 62(19): 1.748-1.758 [DOI: 10.1016/j.jacc.2013.05.071].
3. Kume T, Akasaka T, Kawamoto T, Ogasawara Y, Watanabe N, Toyota E, et al. Assessment of coronary arterial thrombus by optical coherence tomography.
Am J Cardiol. 2006; 97(12): 1.713-1.717 [DOI: 10.1016/j.amjcard.2006.01.031].
4. Kubo T, Imanishi T, Takarada S, Kuroi A, Ueno S, Yamano T, et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical
coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol. 2007; 50(10): 933-939 [DOI: 10.1016/j.jacc.2007.04.082].
5. Jia H, Dai J, Hou J, Xing L, Ma L, Liu H, et al. Effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based
management in plaque erosion (the EROSION study). Eur Heart J. 2017; 38(11): 792-800 [DOI: 10.1093/eurheartj/ehw381].
6. Räber L, Mintz GS, Koskinas KC, Johnson TW, Holm NR, Onumaet Y, et al. Clinical use of intracoronary imaging (I): Guidance and optimization of coronary
interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. EuroIntervention. 2018; 14(6):
656-677 [DOI: 10.4244/EIJY18M06-01].
7. Bezerra HG, Costa MA, Guagliumi G, Rollins AM, Simon DI. Intracoronary optical coherence tomography: a comprehensive review. Clinical and research
applications. JACC Cardiovasc Interv. 2009; 2(11): 1.035-1.046 [DOI: 10.1016/j.jcin.2009.06.019].
8. Guo N, Maehara A, Mintz GS, He Y, Xu K, Wu X, et al. Incidence, mechanisms, predictors, and clinical impact of acute and late stent malapposition after
primary intervention in patients with acute myocardial infarction: an intravascular ultrasound substudy of the Harmonizing Outcomes with Revascularization
and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial. Circulation. 2010; 122(11): 1.077-1.084 [DOI: 10.1161/circulationaha.109.906040].
9. Romagnoli E, Gatto L, La Manna A, Burzotta F, Taglieri N, Saia F, et al. Role of residual acute stent malapposition in percutaneous coronary interventions.
Catheter Cardiovasc Interv. 2017; 90(4): 566-575 [DOI: 10.1002/ccd.26974].
10. Cuesta J, Rivero F, Bastante T, García‑Guimaraes M, Antuña P, Alvarado T, et al. Optical coherence tomography findings in patients with stent thrombosis.
Rev Esp Cardiol (Engl. Ed.). 2017; 70(12): 1.050-1.058 [DOI: 10.1016/j.rec.2017.04.001].
11. Guagliumi G, Sirbu V, Musumeci G, Gerber R, Biondi‑Zoccai G, Ikejima H, et al. Examination of the in vivo mechanisms of late drug-eluting stent throm-
bosis: findings from optical coherence tomography and intravascular ultrasound imaging. JACC Cardiovasc Interv. 2012; 5(1): 12-20 [DOI: 10.1016/j.jcin.2011.09.018].
12. Taniwaki M, Radu MD, Zaugg S, Amabile N, García‑García HM, Yamaji K, et al. Mechanisms of very late drug-eluting stent thrombosis assessed by optical
coherence tomography. Circulation. 2016; 133(7): 650-660 [DOI: 10.1161/circulationaha.115.019071].
13. Souteyrand G, Amabile N, Mangin L, Chabin X, Meneveau N, Cayla G, et al.; PESTO Investigators. Mechanisms of stent thrombosis analysed by optical
coherence tomography: insights from the national PESTO French registry. Eur Heart J. 2016; 37(15): 1.208-1.216 [DOI: 10.1093/eurheartj/ehv711].
14. Adriaenssens T, Joner M, Godschalk TC, Malik N, Alfonso F, Xhepa E, et al.; Prevention of Late Stent Thrombosis by an Interdisciplinary Global
European Effort (PRESTIGE) Investigators. Optical coherence tomography findings in patients with coronary stent thrombosis: a report of the PRESTIGE
consortium (prevention of late stent thrombosis by an interdisciplinary global European effort). Circulation. 2017; 136(11): 1.007-1.021 [DOI: 10.1161/circula-
tionaha.117.026788].
15. Ye Y, Yang M, Zhang S, Zeng Y. Percutaneous coronary intervention in left main coronary artery disease with or without intravascular ultrasound:
a meta-analysis. PLoS One. 2017; 12(6): e0179756 [DOI: 10.1371/journal.pone.0179756].
16. Burzotta F, Dato I, Trani C, Pirozzolo G, De Maria GL, Porto I, et al. Frequency domain optical coherence tomography to assess non-ostial left main
coronary artery. EuroIntervention. 2015; 10(9): e1-e8 [DOI: 10.4244/EIJV10I9A179].
17. Fujino Y, Bezerra HG, Attizzani GF, Wang W, Yamamoto H, Chamié D, et al. Frequency-domain optical coherence tomography assessment of unprotected
left main coronary artery disease - a comparison with intravascular ultrasound. Catheter Cardiovasc Interv. 2013; 82(3): E173-83 [DOI: 10.1002/ccd.24843].

16